Muñoz E, Johnson H, Goldstein J, Benacquista T, Mulloy K, Wise L
J Natl Med Assoc. 1988 Sep;80(9):972-6.
The Medicare diagnostic-related group (DRG) prospective payment model is changing hospital payment. Currently many states are using DRG prospective "all payer systems" for hospital reimbursement. In all payer systems, Medicare, Medicaid, Blue Cross, and other commercial insurers pay by the DRG mode; New York State has had an all payer system since January 1, 1988. This study simulated DRG all payer methods on a large sample (N = 6,134) of adult black medical and surgical patients for a three-year period using both federal and New York DRG reimbursement. Both Medicare and Medicaid patients had, on average, a longer hospital stay and total hospital cost compared with patients covered by Blue Cross and other commercial insurers. Medicare and Medicaid patients also had a greater severity of illness compared with those of Blue Cross and others. All insurers (ie, Medicaid, Blue Cross, Medicare, and commercial) generated substantial financial risk under the DRG all payer scheme. These data suggest that federal, state, and private payers may be under-reimbursing for the care of the hospitalized black patient using the DRG prospective hospital payment scheme. Health care financing policy such as that demonstrated in this study may limit both the access and quality of care for many black patients in the future.
医疗保险诊断相关分组(DRG)前瞻性支付模式正在改变医院的支付方式。目前,许多州正在将DRG前瞻性“全支付方系统”用于医院报销。在所有支付方系统中,医疗保险、医疗补助、蓝十字和其他商业保险公司均按DRG模式支付;自1988年1月1日起,纽约州就实行了全支付方系统。本研究使用联邦和纽约的DRG报销方式,对一个包含6134名成年黑人内科和外科患者的大样本进行了为期三年的DRG全支付方方法模拟。与蓝十字和其他商业保险公司承保的患者相比,医疗保险和医疗补助患者的平均住院时间更长,住院总费用更高。与蓝十字和其他保险公司的患者相比,医疗保险和医疗补助患者的病情也更严重。在DRG全支付方方案下,所有保险公司(即医疗补助、蓝十字、医疗保险和商业保险公司)都产生了巨大的财务风险。这些数据表明,使用DRG前瞻性医院支付方案时,联邦、州和私人支付方可能对住院黑人患者的护理报销不足。本研究中所展示的医疗保健融资政策可能会在未来限制许多黑人患者获得医疗服务的机会和医疗服务质量。